Novel appearance of hyperglycemia/diabetes,associated with COVID-19 |
| |
Authors: | Ioannis Ilias |
| |
Affiliation: | Ioannis Ilias, Department of Endocrinology, Diabetes & Metabolism, Elena Venizelou Hospital, Athens GR-11521, Greece |
| |
Abstract: | In a recent meta-analysis the prevalence of coronavirus disease 2019 (COVID-19)-associated hyperglycemia was 25%, and that of COVID-19-associated new-onset diabetes was 19%. An association between hyperglycemia or new-onset diabetes and COVID-19 has been suggested. In a recent relevant study of critically and non-critically ill patients with COVID-19, we found that indeed beta-cell function was compromised in critically ill patients with COVID-19 and that these patients showed a high glycemic gap. Nevertheless, one quarter of critically ill patients with no history of diabetes have stress hyperglycemia, a finding which could obscure the prevalence of hyperglycemia or new-onset diabetes that could be attributed to COVID-19 per se. |
| |
Keywords: | Blood glucose Pandemics Severe acute respiratory syndrome coronavirus 2 Humans Hyperglycemia Hospitalization |
|
| 点击此处可从《World Journal of Virology》浏览原始摘要信息 |
|